Mesagne, Italy

Angelo Michele Rizzo


Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Inventor Profile: Angelo Michele Rizzo

Introduction

Angelo Michele Rizzo is a noteworthy inventor hailing from Mesagne, Italy. With a keen focus on antibiotic production, he has made significant contributions to the field through his innovative approaches and methodologies.

Latest Patents

Rizzo holds a patent titled "Process for the selective increase of production of antibiotic GE 2270." This groundbreaking method aims to enhance antibiotic yield, particularly by promoting the selective production of factor A of the GE 2270 antibiotic. The process involves the addition of vitamin B12 or its analogs, exhibiting vitamin B12-like activity, to the fermentation media of Planobispora rosea ATCC 53773 or any GE 2270-producing mutant or variant thereof. This innovation underscores Rizzo's commitment to improving antibiotic production, which is crucial in the fight against bacterial infections.

Career Highlights

Angelo Michele Rizzo is currently associated with Gruppo Lepetit S.p.a., where he applies his expertise in microbiology and fermentation technology. His work at the company illustrates his dedication to advancing pharmaceutical developments, particularly in antibiotic research.

Collaborations

In his career, Rizzo has collaborated with distinguished coworker Luciano Gastaldo, working together on various projects that contribute to enhanced antibiotic production technologies. Their partnership highlights the importance of collaboration in scientific research and innovation.

Conclusion

Angelo Michele Rizzo's contributions to antibiotic production through his innovative patent reflect his significant role as an inventor in the pharmaceutical industry. His work not only benefits his company, Gruppo Lepetit S.p.a., but potentially the healthcare sector at large by addressing the pressing need for effective antibiotics.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…